《新股消息》傳伊美爾醫療科技赴港上市 集資3億美元
據《路透社》旗下IFR引述消息人士指,北京伊美爾醫療科技計劃透過在港上市,集資約3億美元。伊美爾醫療已於8月初向聯交所提交上市申請,由海通國際擔任獨家保薦人。
初步招股文件顯示,伊美爾醫療為內地私立醫療美容機構集團,主要提供醫療美容非手術服務及醫療美容手術服務。截至今年3月底,該集團共設有9家醫療美容機構,擁有157名執業醫師。首季診療人次達11.15萬人,每次診療平均費用約2,278元人民幣。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.